- Professorial Lecturer in Law
- 2000 H Street, NW
Washington, District Of Columbia 20052
Robert Leibenluft is a partner in the Washington, D.C. office of Hogan Lovells, LLP, where his practice is devoted entirely to health and antitrust matters, including counseling and litigation regarding antitrust issues involving hospitals, physicians, health plans, manufacturers of medical devices and pharmaceuticals, and other health sector companies.
Upon completing law school, Mr. Leibenluft worked as an attorney advisor in the Federal Trade Commission (FTC)'s Office of Policy Planning, concentrating on health and antitrust matters. In 1981, he joined Hogan & Hartson and became a partner in the firm in 1989. He practiced health regulatory law at Hogan & Hartson until January 1996 when he rejoined the FTC as Assistant Director for Health Care in the FTC’s Bureau of Competition. As head of the Health Care Division, Mr. Leibenluft supervised a 25-30 person staff engaged in the review of mergers and joint ventures involving hospitals, physicians, and other health care providers, as well as conduct in the health and pharmaceutical industries. During his tenure, the FTC and DOJ issued its most recent Statements of Antitrust Enforcement in Health Care. He rejoined Hogan & Hartson (now Hogan Lovells) in 1998.
Mr. Leibenluft is an inaugural Fellow and former Vice-President of the American Health Lawyers Association. He is also a former Chair of the Health and Pharmaceuticals Committee, the State Antitrust Enforcement Committee, and the Joint Conduct Committee of the ABA Antitrust Section. Mr. Leibenluft currently serves as Chair of the Board of Directors of Health Care Incentives Institute, Inc. (HCI3), which is the parent organization of Prometheus Payment, Inc. and Bridges-to-Excellence. He is a frequent speaker and author on health antitrust issues, and his articles have appeared in Health Affairs, The New England Journal of Medicine, and other publications.
BA, Yale University; JD, University of California at Berkeley